Mometasona Viso Farmacéutica (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Viso Farmacéutica, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory skin conditions such as psoriasis, atopic dermatitis and eczema in adults and children as directed by a healthcare professional.

GNH USA supplies Mometasona Viso Farmacéutica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical corticosteroid used to manage inflammatory skin disorders.

- Psoriasis: reduces scaling, redness and itching associated with plaque psoriasis. - Atopic dermatitis: alleviates inflammation and pruritus in eczema flare‑ups. - Eczema: controls skin inflammation and improves lesion appearance.

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Skin irritation: mild burning, stinging or itching at the application site. - Dryness: localized skin dryness or flaking. - Erythema: transient redness of the treated area. - Folliculitis: occurrence of small pustules around hair follicles.

Serious or Rare Side Effects: - Hypothalamic‑pituitary‑adrenal (HPA) axis suppression: systemic effects with extensive use. - Skin atrophy: thinning of the epidermis and dermis with prolonged therapy. - Secondary infection: bacterial, fungal or viral infection of the treated skin.

When using Mometasona Viso Farmacéutica, several precautions should be observed to minimize risks. - Application area: limit use to affected skin and avoid large surface areas. - Duration: do not exceed recommended treatment length without medical review. - Occlusion: avoid covering treated skin with dressings unless directed. - Age restrictions: use in children only under supervision of a healthcare professional. - Systemic absorption: monitor for signs of systemic corticosteroid effects in extensive use. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Mometasone furoate may interact with other topical or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can increase risk of systemic side effects. - CYP3A4 inhibitors (e.g., ketoconazole cream): may raise local drug levels, enhancing adverse effects. - Antifungal agents: combined use may alter skin barrier and increase absorption.

Moderate Interactions (Monitor Closely): - Skin‑sensitizing agents (e.g., retinoids): may increase irritation. - Immunosuppressants (e.g., systemic cyclosporine): monitor for additive immunosuppression. - Phototherapy: assess for enhanced photosensitivity.